Nona Biosciences Unveils AI-Assisted Hu-mAtrIx™ Platform to Revolutionize Antibody Discovery

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM),  announced to unveil its innovative AI-...

March 07, 2025 | Friday | News
Codoxo Unveils AI Data Health Integrity Agent to Streamline Claims Data Sharing for Healthcare Payers

Codoxo, the leading provider of artificial intelligence solutions in payment integrity and cost containment for healthcare payers, government agencies and ...

March 05, 2025 | Wednesday | News
23andMe Board Rejects CEO Anne Wojcicki’s Lowball Buyout Offer, Raising Big Questions for Investors

The Special Committee of the Board of Directors of 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME) today confirmed ...

March 04, 2025 | Tuesday | Analysis
SK bioscience Secures PAHO Contract Extension to Supply SKYVaricella® to Latin America Through 2027

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that the compan...

February 28, 2025 | Friday | News
HBM Alpha Therapeutics Partners with Global Business Partner to Advance CRH-targeting Therapy for Endocrine Disorders

HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed, announced a strategic collaboration and license...

February 26, 2025 | Wednesday | News
Miltenyi Biotec Expands Global Footprint with New Cell & Gene Therapy Center in India’s Genome Valley

  Miltenyi Biotec, a global leader in cell and gene therapy solutions, has inaugurated a cutting-edge Cell & Gene Therapy Center in Genome Valley...

February 25, 2025 | Tuesday | News
Incyte and Genesis Therapeutics Forge Strategic Collaboration to Accelerate Small Molecule Drug Discovery Using AI

Incyte  and Genesis Therapeutics, Inc. announced  that the companies have entered into a strategic collaboration focused on the researc...

February 21, 2025 | Friday | News
Ilona Holcomb on How ImpriMed’s AI is Transforming Cancer Treatment for Pets and Humans

Artificial intelligence is reshaping oncology, and ImpriMed is at the forefront of this transformation. With its AI-powered Personalized Prediction Profi...

February 18, 2025 | Tuesday | Interview
Aveva Drug Delivery Systems Launches Generic Fentanyl Transdermal Patch in the US Market

Aveva Drug Delivery systems (A DifGen company), a leader in transdermal drug delivery systems based out of Miramar - Florida is proud t...

February 18, 2025 | Tuesday | News
Kessler Foundation Achieves Breakthrough in Spinal Cord Injury Treatment with First Epidural Spinal Stimulator Implant

The Tim and Caroline Reynolds Center for Spinal Stimulation at Kessler Foundation is proud to announce the implantation of a spinal cord epidural stim...

February 12, 2025 | Wednesday | News
Thailand FDA Approves NERLYNX® to Reduce Breast Cancer Recurrence and Improve Survival Outcomes

A NEW breast cancer therapy shown to significantly reduce the risk of cancer recurrence and improve disease-free survival in women is now approved for use ...

February 12, 2025 | Wednesday | News
Intuitive BioTechnologies Expands Elemental Analysis Services in North America

Intuitive BioTechnologies LLC (IBT) is proud to announce they have added elemental analysis to their testing capabilities. IBT is now offering quantitati...

February 07, 2025 | Friday | News
Illumina’s CEO Jacob Thaysen Drives Strategic Growth as Q4 Revenue Surpasses Expectations

      Illumina, led by CEO Jacob Thaysen, delivered a Q4 revenue of $1.1 billion, reflecting a steady 1% year-over-year increase, w...

February 07, 2025 | Friday | Company results
BioMed X and Merck Reveal Critical Insights on Extrachromosomal DNA in Cancer Paving the Way for Novel Therapies

The research of BioMed X team EDC - Extrachromosomal DNA in Cancer - has uncovered critical insights into the mechanisms driving extrachromosomal ...

February 06, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close